Related Experiment Video
Updated: Aug 22, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Early-life adverse events and risk of inflammatory bowel disease: A Scandinavian birth cohort study
Ida Sigvardsson1, Ketil Størdal2,3, Henrik Imberg4,5
1Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
Objectives:
The experience of childhood stressful or adverse life events is believed to imprint on immunological pathways and, therefore, might have lasting effects on inflammatory bowel disease (IBD) development. This study aimed to examine the association between experiences of early-life adverse events and later IBD risk.
Methods:
We followed children in the Norwegian Mother, Father, and Child Cohort Study (MoBa) and All Babies in Southeast Sweden cohort (ABIS) from birth (1997-2009) and linked cohort data to national patient registers to identify IBD diagnoses through the end of 2024 and 2023, respectively. We included 111,293 participants with data on adverse life events reported during pregnancy, by age 1, or by age 3. Adverse life events included adverse maternal or familial events, such as divorce or loss of a family member, based on questionnaire data from the two prospective birth cohorts. Cox regression was used to estimate adjusted hazard ratios (aHRs) for IBD in children exposed versus unexposed to adverse maternal or family events, accounting for parental and child characteristics. Cohort-specific estimates were pooled using a random effects model.
Results:
We identified 697 IBD events over 2,255,642 person-years of follow-up. Experience of maternal adverse events in pregnancy, reported by 22% of the mothers, was not associated with offspring IBD; pooled aHR 1.00 (95% confidence interval [CI] = 0.57-1.76), compared with no experience. Neither experience of adverse family events by age 1 year (pooled aHR 0.96, 95% CI = 0.80-1.15), nor by age 3 years (pooled aHR 0.99, 95% CI = 0.83-1.17) was associated with later IBD.
Conclusions:
This bi-national prospective cohort study found no support for the hypothesis that experiences of early-life adverse events increase the risk of IBD.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Development of Human Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
